Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Ulcerative Colitis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-1926
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Ulcerative Colitis ; day:12 ; month:5 ; year:2018 ; pages:1-23
Clinical pharmacokinetics ; (12.5.2018), 1-23
- Urheber
-
Berends, Sophie E.
- Beteiligte Personen und Organisationen
-
Strik, Anne S.
Löwenberg, Mark
D’Haens, Geert R.
Mathôt, Ron A. A.
SpringerLink (Online service)
- DOI
-
10.1007/s40262-018-0676-z
- URN
-
urn:nbn:de:101:1-2018071619075525349556
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:25 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Berends, Sophie E.
- Strik, Anne S.
- Löwenberg, Mark
- D’Haens, Geert R.
- Mathôt, Ron A. A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Population pharmacokinetic analysis of infliximab in patients with ulcerative colitis
Viral Hepatitis C Therapy: Pharmacokinetic and Pharmacodynamic Considerations: A 2019 Update
Central Nervous System Medications: Pharmacokinetic and Pharmacodynamic Considerations for Older Adults
Ivermectin to reduce malaria transmission I. Pharmacokinetic and pharmacodynamic considerations regarding efficacy and safety
Ulcerative colitis - Crohn's disease
Ulcerative Colitis: Shifting Sands
Apixaban: A Clinical Pharmacokinetic and Pharmacodynamic Review
A Population Pharmacokinetic-Pharmacodynamic Model of Pegfilgrastim
Clinical Pharmacokinetic and Pharmacodynamic Profile of Riociguat
Clinical Pharmacokinetic and Pharmacodynamic Profile of Vericiguat
Pharmacokinetic and pharmacodynamic considerations for antifungal therapy optimisation in the treatment of intra-abdominal candidiasis
Specific immunotherapy ameliorates ulcerative colitis
Population pharmacokinetic analysis of infliximab in patients with ulcerative colitis
Viral Hepatitis C Therapy: Pharmacokinetic and Pharmacodynamic Considerations: A 2019 Update
Central Nervous System Medications: Pharmacokinetic and Pharmacodynamic Considerations for Older Adults
Ivermectin to reduce malaria transmission I. Pharmacokinetic and pharmacodynamic considerations regarding efficacy and safety
Ulcerative colitis - Crohn's disease
Ulcerative Colitis: Shifting Sands
Apixaban: A Clinical Pharmacokinetic and Pharmacodynamic Review
A Population Pharmacokinetic-Pharmacodynamic Model of Pegfilgrastim
Clinical Pharmacokinetic and Pharmacodynamic Profile of Riociguat
Clinical Pharmacokinetic and Pharmacodynamic Profile of Vericiguat
Pharmacokinetic and pharmacodynamic considerations for antifungal therapy optimisation in the treatment of intra-abdominal candidiasis
Specific immunotherapy ameliorates ulcerative colitis
Population pharmacokinetic analysis of infliximab in patients with ulcerative colitis
Viral Hepatitis C Therapy: Pharmacokinetic and Pharmacodynamic Considerations: A 2019 Update
Central Nervous System Medications: Pharmacokinetic and Pharmacodynamic Considerations for Older Adults
Ivermectin to reduce malaria transmission I. Pharmacokinetic and pharmacodynamic considerations regarding efficacy and safety
Ulcerative colitis - Crohn's disease
Ulcerative Colitis: Shifting Sands
Apixaban: A Clinical Pharmacokinetic and Pharmacodynamic Review
A Population Pharmacokinetic-Pharmacodynamic Model of Pegfilgrastim
Clinical Pharmacokinetic and Pharmacodynamic Profile of Riociguat
Clinical Pharmacokinetic and Pharmacodynamic Profile of Vericiguat
Pharmacokinetic and pharmacodynamic considerations for antifungal therapy optimisation in the treatment of intra-abdominal candidiasis